Skip to main navigation Skip to search Skip to main content

Ph-positive CML in blastic phase with monosomy 7 in a Down syndrome patient. Monitoring by interphase cytogenetics and demonstration of maternal allelic loss

  • Laura Seghezzi
  • , Claudia Dellavecchia
  • , Emanuela Maserati
  • , Antonella Minelli
  • , Annamaria Carrà
  • , Franco Locatelli
  • , Alessandra Argusti
  • , Francesco Lo Curto
  • , Cesare Danesino
  • , Francesco Pasquali
  • University of Pavia
  • E.O. Ospedali Galliera

Research output: Contribution to journalArticle

Abstract

We report a case of Ph-positive chronic myelocytic leukemia in blastic phase in an 11-year-old boy with Down syndrome. Monosomy 7 was the only additional chromosomal anomaly in the blastic clone. Fluorescence in situ hybridization analysis on interphase nuclei with a centromeric probe specific to chromosome 7 proved to be efficient in disease monitoring, and showed, together with the results of chromosome analysis on metaphases, that B-lymphocytes at the origin of an EBV-established line were not part of the leukemic clone. The study of DNA polymorphisms showed that the origin of the constitutional trisomy 21 was a maternal anaphase I nondisjunction, that the chromosome 7 lost in the blastic marrow clone was the maternal one, and led us to postulate that the mother's chromosomes are prone to impairment of normal disjunction. The study of allelic losses of chromosome 7 loci proved to be a further possibility for disease monitoring. (C) Elsevier Science Inc., 1997.
Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume99
DOIs
Publication statusPublished - 1997

Keywords

  • Down Syndrome / genetics

Fingerprint

Dive into the research topics of 'Ph-positive CML in blastic phase with monosomy 7 in a Down syndrome patient. Monitoring by interphase cytogenetics and demonstration of maternal allelic loss'. Together they form a unique fingerprint.

Cite this